Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011

Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance

Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050

Grading quality of evidence and strength of recommendations

(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477

Bariatric Surgery: A Systematic Review and Meta-analysis

Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)

The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138

Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome

Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457

Office Blood Pressure, Ambulatory Blood Pressure Monitoring, and Echocardiographic Abnormalities in Women With Polycystic Ovary Syndrome

Luque‐Ramírez, M., Sánchez, D. M., Fernández‐Durán, E., Alpañés, M., Álvarez‐Blasco, F., & Escobar-Morreale, H. F. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.02468 · Cited by 35

Proteomics and polycystic ovary syndrome

Insenser, M. R., & Escobar-Morreale, H. F. (2013) · Expert Review of Proteomics · doi:10.1586/14789450.2013.837665 · Cited by 35

Evolutionary determinants of polycystic ovary syndrome: part 1

Ünlütürk, U., Sezgın, E., & Yıldız, B. O. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.010 · Cited by 36

Blood Trace Element Concentrations in Polycystic Ovary Syndrome: Systematic Review and Meta-analysis

Spritzer, P. M., Lecke, S. B., Fabris, V. C., Ziegelmann, P. K., & Amaral, L. (2016) · Biological Trace Element Research · doi:10.1007/s12011-016-0774-4 · Cited by 36

Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China

Feng, J., Guo, Y., Ma, L., Xing, J., Sun, R., & Zhu, W. (2017) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.12387 · Cited by 36

Hypertension Risk in Young Women With Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study

Wu, C.-H., Chiu, L., Chang, Y., Lee, C., Lee, M., Lee, T., & Wei, J. C. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.574651 · Cited by 36

MIF-mediated NF-κB signaling pathway regulates the pathogenesis of polycystic ovary syndrome in rats

He, Z., Wang, Y., Li, Z., Li, Y., Tang, Z.-O., Wu, Z., & Ma, Y. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155632 · Cited by 36

Bifidobacterium Is Enriched in Gut Microbiome of Kashmiri Women with Polycystic Ovary Syndrome

Hassan, S., Kaakinen, M., Draisma, H. H. M., Zudina, L., Ganie, M. A., Rashid, A., Balkhiyarova, Z., Kiran, G. S., Vogazianos, P., Shammas, C., et al. (2022) · Genes · doi:10.3390/genes13020379 · Cited by 37

Age Associated Differences in Prevalence of Individual Rotterdam Criteria and Metabolic Risk Factors During Reproductive Age in 446 Caucasian Women with Polycystic Ovary Syndrome

Glintborg, D., Mumm, H., Ravn, P., & Andersen, M. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0032-1304608 · Cited by 36

FTO gene variants are not associated with polycystic ovary syndrome in women from Southern Brazil

Ramos, R. B., & Spritzer, P. M. (2015) · Gene · doi:10.1016/j.gene.2015.01.012 · Cited by 35

Lipoprotein Particles in Adolescents and Young Women With PCOS Provide Insights Into Their Cardiovascular Risk

Gourgari, E., Lodish, M. B., Shamburek, R. D., Keil, M. F., WESLEY, R. A., Walter, M. F., Sampson, M. L., Bernstein, S. B., Khurana, D., Lyssikatos, C., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2566 · Cited by 35

Translational Insight Into Polycystic Ovary Syndrome (PCOS) From Female Monkeys with PCOS-like Traits

Abbott, D., Levine, J. E., & Dumesic, D. A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160715133437 · Cited by 36

Polycystic ovary syndrome and periodontal disease: Underlying links- A review

Tanguturi, S. C., & Nagarakanti, S. (2018) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_577_17 · Cited by 37

The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women

Valderhaug, T. G., Hertel, J. K., Nordstrand, N., Dale, P. O., Hofsø, D., & Hjelmesaeth, J. S. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0040-5 · Cited by 35

Uncertainty Remains in Women with PCOS Regarding the Increased Incidence of Cardiovascular Disease Later in Life, Despite the Indisputable Presence of Multiple Cardiovascular Risk Factors at a Young Age

Fauser, B. C. J. M., & Bouchard, P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2935 · Cited by 35

Clinical, Hormonal, and Metabolic Parameters in Women with Subclinical Hypothyroidism and Polycystic Ovary Syndrome: A Cross-Sectional Study

Bedaiwy, M. A., Abdel-Rahman, M., Tan, J., AbdelHafez, F. F., Abdelkareem, A. O., Henry, D., Lisonkova, S., Hurd, W. W., & LIU, J. H. (2018) · Journal of Women s Health · doi:10.1089/jwh.2017.6584 · Cited by 35

High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS)

Ganie, M. A., Hassan, S., Nisar, S., Shamas, N., Rashid, A., Ahmed, I., Douhat, S., Mudassar, S., Jan, V. M., & Rashid, F. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.924099 · Cited by 34

Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome

Amato, M. C., Magistro, A., Gambino, G., Vesco, R., & Giordano, C. S. D. S. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0600 · Cited by 34

Low Free Testosterone Levels Are Associated With All-Cause and Cardiovascular Mortality in Postmenopausal Diabetic Women

Wehr, E., Pilz, S., Boehm, B. O., Grammer, T. B., März, W., & Obermayer-Pietsch, B. M. (2011) · Diabetes Care · doi:10.2337/dc11-0596 · Cited by 34

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome

Shahebrahimi, K., Jalilian, N., Bazgir, N., & Rezaei, M. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.192925 · Cited by 34

Effect of GLP-1 Receptor Agonists in the Cardiometabolic Complications in a Rat Model of Postmenopausal PCOS

Fernandez, E. D. T., Huffman, A. M., Syed, M., Romero, D. G., & Cardozo, L. L. Y. (2019) · Endocrinology · doi:10.1210/en.2019-00450 · Cited by 35

Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study

Sathyapalan, T., Smith, K. A., Coady, A., Kilpatrick, E. S., & Atkin, S. L. (2011) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011071 · Cited by 34

Increased Androgen, Anti-Müllerian Hormone, and Sporadic Anovulation in Healthy, Eumenorrheic Women: A Mild PCOS-Like Phenotype?

Sjaarda, L. A., Mumford, S. L., Kissell, K., Schliep, K. C., Hammoud, A. O., Perkins, N. J., Weck, J., Wactawski‐Wende, J., & Schisterman, E. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3781 · Cited by 34

Is There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?

Carmina, E., & Lobo, R. A. (2018) · Journal of Women s Health · doi:10.1089/jwh.2018.7162 · Cited by 34

Therapeutic exploration of polyherbal formulation against letrozole induced PCOS rats: A mechanistic approach

Balasubramanian, A., Pachiappan, S., Mohan, S., Harikrishnan, A., Karuppasamy, I., & Ramalingam, K. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15488 · Cited by 33

Polycystic Ovary Syndrome, Insulin Resistance, and Cardiovascular Disease

Dubey, P., Reddy, S., Sharma, K., Johnson, S., Hardy, G., & Dwivedi, A. K. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02050-5 · Cited by 38

Endocrine and metabolic characteristics of polycystic ovary syndrome in Chinese women with different phenotypes

Xu, X., Shi, Y., Cui, Y., Ma, J., Che, L., & Chen, Z. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04194.x · Cited by 33

Predictors of Subclinical Cardiovascular Disease in Women with Polycystic Ovary Syndrome: Interrelationship of Dyslipidemia and Arterial Blood Pressure

Μacut, D., Bačević, M., Antić, I. B., Bjekić-Macut, J., Čivčić, M., Erceg, S., Milutinović, D. V., Stanojlović, O. P., Andric, Z. G., Kastratović-Kotlica, B., et al. (2015) · International Journal of Endocrinology · doi:10.1155/2015/812610 · Cited by 33

The role of anti-Müllerian hormone in the classification of anovulatory infertility

Fong, S. L., Schipper, I., Valkenburg, O., de Jong, F. H., Visser, J. A., & Laven, J. S. E. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.01.007 · Cited by 33

Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome

Huang, G. T.-W., & Coviello, A. D. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32835a000e · Cited by 34

Genetic association studies in female reproduction: from candidate-gene approaches to genome-wide mapping

Zhao, H., & Chen, Z. (2013) · Molecular Human Reproduction · doi:10.1093/molehr/gat040 · Cited by 33

Diagnosis of disorders of glucose tolerance in women with polycystic ovary syndrome (PCOS) at a tertiary care center: fasting plasma glucose or oral glucose tolerance test?

Ortiz-Flores, A. E., Luque‐Ramírez, M., Fernández‐Durán, E., Álvarez‐Blasco, F., & Escobar-Morreale, H. F. (2019) · Metabolism · doi:10.1016/j.metabol.2019.01.015 · Cited by 33

Hyperandrogenism Enhances Muscle Strength After Progressive Resistance Training, Independent of Body Composition, in Women With Polycystic Ovary Syndrome

Kogure, G. S., Silva, R. C., Furtado, C. L. M., Ribeiro, V. B., Pedroso, D. C. C., de Melo, A. S., Ferriani, R. A., & dos Reis, R. M. (2018) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000002714 · Cited by 33

Age‐stratified thresholds of anti‐Müllerian hormone improve prediction of polycystic ovary syndrome over a population‐based threshold

Quinn, M. M., Kao, C., Ahmad, A., Haisenleder, D. J., Santoro, N. F., Eisenberg, E., Legro, R. S., Cedars, M. I., Huddleston, H. G., & the NIH/NICHD Reproductive Medicine Network (2017) · Clinical Endocrinology · doi:10.1111/cen.13415 · Cited by 32

Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome

Krentowska, A., Łebkowska, A., Jacewicz‐Święcka, M., Hryniewicka, J., Leśniewska, M., Adamska, A., & Kowalska, I. (2021) · Endocrine · doi:10.1007/s12020-020-02596-8 · Cited by 32

Novel adipokines WISP1 and betatrophin in PCOS: relationship to AMH levels, atherogenic and metabolic profile

Ersoy, G. Ş., Ensarı, T. A., Vatansever, D., Emirdar, V., & Çevik, Ö. D. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1223286 · Cited by 32

Diet-Induced Weight Loss Reduces DNA Damage and Cardiometabolic Risk Factors in Overweight/Obese Women with Polycystic Ovary Syndrome

Soares, N. P., Santos, A. C. S. D., Costa, E. C., Azevedo, G. D., Damasceno, D. C., Fayh, A. P. T., & Lemos, T. M. A. M. (2016) · Annals of Nutrition and Metabolism · doi:10.1159/000444130 · Cited by 31

The obesogen tributyltin induces features of polycystic ovary syndrome (PCOS): a review

Merlo, E., Silva, I. V., Cardoso, R. C., & Graceli, J. B. (2018) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2018.1496214 · Cited by 32

Neurotransmitter, neuropeptide and gut peptide profile in PCOS-pathways contributing to the pathophysiology, food intake and psychiatric manifestations of PCOS

Ilie, I. R. P. (2019) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.11.004 · Cited by 32

The Association of Serum Levels of Leptin and Ghrelin with the Dietary Fat Content in Non-Obese Women with Polycystic Ovary Syndrome

Polak, A. M., Krentowska, A., Łebkowska, A., Buczyńska, A., Adamski, M., Adamska-Patruno, E., Fiedorczuk, J., Krętowski, A. J., Kowalska, I., & Adamska, A. (2020) · Nutrients · doi:10.3390/nu12092753 · Cited by 31

Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome

Şahin, F. K., Şahin, S. B., Ural, Ü. M., Cüre, M. C., Şentürk, Ş., Tekın, Y. B., Balık, G., Cüre, E., Yuce, S., & Kırbaş, A. (2015) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2015.432 · Cited by 31

Serum Heat Shock Protein 70 Concentration in Relation to Polycystic Ovary Syndrome in a Non-Obese Chinese Population

Gao, H. Y., Meng, J., Xu, M., Zhang, S., Bishwajit, G., Liu, J., Yao, P., Yan, H., Wang, D., & Liu, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067727 · Cited by 31

Association of follicle-stimulating hormone levels and risk of type 2 diabetes in older postmenopausal women

Bertone‐Johnson, E. R., Virtanen, J. K., NISKANEN, L. K., Nurmi, T., Ronkainen, K., Voutilainen, S., Mursu, J., Kauhanen, J., & Tuomainen, T. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000834 · Cited by 32

Effects of Synbiotic Supplementation and Lifestyle Modifications on Women With Polycystic Ovary Syndrome

Chudzicka-Strugała, I., Kubiak, A., Banaszewska, B., Zwoździak, B., Siakowska, M., Pawelczyk, L. A., & Dulęba, A. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab369 · Cited by 32

Targeting adipokines in polycystic ovary syndrome and related metabolic disorders: from experimental insights to clinical studies

Xu, Y., Zhu, H., Li, W., Chen, D., Xu, Y., Xu, A., & Ye, D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108284 · Cited by 31

Cardiovascular disease risk in young Indian women with polycystic ovary syndrome

Guleria, A. K., Syal, S., Kapoor, A., Kumar, S., Tiwari, P., & Dabadghao, P. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.831835 · Cited by 29

Women with Polycystic Ovary Syndrome and Risk of Cardiovascular Disease

Perović-Blagojević, I., Eror, T., Jovana, P., Jelić, S., Kotur‐Stevuljević, J., & Ignjatović, S. (2017) · Journal of Medical Biochemistry · doi:10.1515/jomb-2017-0020 · Cited by 29

Integrated Model of Care for Polycystic Ovary Syndrome

Tay, C. T., Moran, L., Wijeyaratne, C. N., Redman, L. M., Norman, R. J., Teede, H. J., & Joham, A. E. (2018) · Seminars in Reproductive Medicine · doi:10.1055/s-0038-1667310 · Cited by 29

Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients

Tedesco, S., Adorni, M. P., Ronda, N., Cappellari, R., Mioni, R., Barbot, M., Pinelli, S., Plebani, M., Bolego, C., Scaroni, C. M., et al. (2019) · Endocrine · doi:10.1007/s12020-019-01911-2 · Cited by 29

Female infertility in the era of obesity: The clash of two pandemics or inevitable consequence?

Medenica, S., Spoltore, M. E., Ormazabal, P., Marina, L., Šojat, A. S., Faggiano, A., Gnessi, L., Mazzilli, R., & Watanabe, M. (2022) · Clinical Endocrinology · doi:10.1111/cen.14785 · Cited by 32

Polycystic ovary syndrome – Phenotypes and diagnosis

Christakou, C. D., & Diamanti‐Kandarakis, E. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.936675 · Cited by 29

The association between androgen receptor gene CAG polymorphism and polycystic ovary syndrome: a case-control study and meta-analysis

Peng, C. Y., Xie, H., Guo, Z. F., Nie, Y. L., Chen, J., Zhou, J. M., & Yin, J. (2014) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-014-0286-0 · Cited by 29

Allopregnanolone involvement in feeding regulation, overeating and obesity

Holmberg, E., Sjöstedt, J., Malinina, E., Johansson, M., Türkmen, Ş., Ragagnin, G., Lundqvist, A., Löfgren, M., Jaukkuri, L., Bixo, M., et al. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.07.002 · Cited by 30

Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome

Lazaridou, S., Dinas, K., & Tziomalos, K. (2017) · HORMONES · doi:10.14310/horm.2002.1757 · Cited by 27

Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome.

Velija-Ašimi, Z., Bureković, A., Dujić, T., Dizdarević-Bostandžić, A., & Semiz, S. (2016) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2016.1428 · Cited by 26

The PCOS Patients differ in Lipid Profile According to their Phenotypes

Spałkowska, M., Mrozińska, S., Gałuszka-Bednarczyk, A., Gosztyła, K., Przywara, A., Guzik, J., Janeczko, M., Milewicz, T., & Wojas‐Pelc, A. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-121264 · Cited by 28

Smoking is associated with increased adrenal responsiveness, decreased prolactin levels and a more adverse lipid profile in 650 white patients with polycystic ovary syndrome

Glintborg, D., Mumm, H., HOUGAARD, D. M., Ravn, P., & Andersen, M. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.589926 · Cited by 28

Effectiveness of Bariatric Surgery in Reducing Weight and Body Mass Index Among Hispanic Adolescents

Cruz-Munoz, N. F. D. L., Lopez‐Mitnik, G., Arheart, K. L., Miller, T. L., Lipshultz, S. E., & Messiah, S. E. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0730-0 · Cited by 28

Acute exercise elicits differential expression of insulin resistance genes in the skeletal muscle of patients with polycystic ovary syndrome

Dantas, W. S., Murai, I. H., Perandini, L. A., de Azevedo, H. F. Z., Moreira‐Filho, C. A., Câmara, N. O. S., Roschel, H., & Gualano, B. (2017) · Clinical Endocrinology · doi:10.1111/cen.13307 · Cited by 28

Anterior Segment Findings in Women with Polycystic Ovary Syndrome

Adıyeke, S. K., Karaca, I. O., Karaca, S. Y., Adıyeke, M., Uyar, İ., & Türe, G. (2017) · Turkish Journal of Ophthalmology · doi:10.4274/tjo.73659 · Cited by 27

Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta‐analysis

Tang, X., Sun, Z., & Gong, L. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13462 · Cited by 28

Correlation between Hashimoto’s thyroiditis and polycystic ovary syndrome: A systematic review and meta-analysis

Hu, X., Chen, Y., Shen, Y., Zhou, S., Fei, W., Yang, Y., & Que, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1025267 · Cited by 30

Effects of androgen excess and body mass index on endothelial function in women with polycystic ovary syndrome

Berbrier, D. E., Leone, C. A., Adler, T. E., Bender, J. R., Taylor, H. S., Stachenfeld, N. S., & Usselman, C. W. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00583.2022 · Cited by 27

Family association study between melatonin receptor gene polymorphisms and polycystic ovary syndrome in Han Chinese

Song, X., Sun, X., Ma, G., Sun, Y. S., Shi, Y., Du, Y., & Chen, Z. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.09.043 · Cited by 27

Poor quality diet is associated with overweight status and obesity in patients with polycystic ovary syndrome

Rodrigues, A. M. D. S., Martins, L. B., Franklin, A. M. T., Cândido, A. L., dos Santos, L. C., & Ferreira, A. V. M. (2014) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12205 · Cited by 28

Correlation of visfatin levels and lipoprotein lipid profiles in women with polycystic ovary syndrome undergoing ovarian stimulation

Tsouma, I., Kouskouni, E. E., Demeridou, S., Boutsikou, M., Hassiakos, D., Chasiakou, A., Hassiakou, S., & Baka, S. G. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.896896 · Cited by 27

The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome

Vieira, C. S., Martins, W. P., Fernandes, J. B. F., Soares, G. M., dos Reis, R. M., de Sá, M. F. S., & Ferriani, R. A. (2012) · Contraception · doi:10.1016/j.contraception.2011.12.011 · Cited by 27

Sex-Specific Disparities in Risk Factors for Coronary Heart Disease

Rosen, S. E., Henry, S. A., Bond, R. M., Pearte, C. A., & Mieres, J. H. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0523-8 · Cited by 26

Central adiposity and decreased heart rate variability in postmenopause: a cross-sectional study

Franz, R. F., Maturana, M. A., Magalhães, J. A. D. A., Moraes, R. S., & Spritzer, P. M. (2012) · Climacteric · doi:10.3109/13697137.2012.745123 · Cited by 26

Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome

Veltman-Verhulst, S. M., Goverde, A. J., van Haeften, T. W., & Fauser, B. C. J. M. (2013) · Human Reproduction · doi:10.1093/humrep/det226 · Cited by 25

Outcomes of a Mindfulness-Based Healthy Lifestyle Intervention for Adolescents and Young Adults with Polycystic Ovary Syndrome

Young, C. C., Monge, M. C., Minami, H., Rew, L., Conroy, H. E., Peretz, C., & Tan, L. (2021) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2021.10.016 · Cited by 26

Identification of the shared gene signatures and pathways between polycystic ovary syndrome and endometrial cancer: An omics data based combined approach

Miao, C., Chen, Y., Fang, X., Zhao, Y., Wang, R., & Zhang, Q. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271380 · Cited by 27

Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals’ Model: In Vitro and In Vivo Studies

Hussain, L., Aamir, N., Hussain, M., Asif, M., Chauhdary, Z., Manzoor, F., Siddique, R., & Riaz, M. S. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/5143653 · Cited by 26

Adult‐type hypolactasia and calcium intake in polycystic ovary syndrome

Lerchbaum, E., Giuliani, A., Gruber, H., Pieber, T. R., & Obermayer-Pietsch, B. M. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04334.x · Cited by 26

Surgical management of metabolic dysfunction in PCOS

Escobar-Morreale, H. F. (2011) · Steroids · doi:10.1016/j.steroids.2011.12.004 · Cited by 26

Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome

Witchel, S. F., Recabarren, S. E., González, F., Diamanti‐Kandarakis, E., Cheang, K. I., Dulęba, A. J., Legro, R. S., Homburg, R., Pasquali, R., Løbo, R. A., et al. (2012) · Endocrine · doi:10.1007/s12020-012-9701-4 · Cited by 26

Insulin resistance assessment in patients with polycystic ovary syndrome using different diagnostic criteria--impact of metformin treatment.

Nawrocka-Rutkowska, J., Ciećwież, S. M., Marciniak, A., Brodowska, A., Wiśniewska, B., Kotlęga, D., & Starczewski, A. (2013) · PubMed · Cited by 26

In VitroFertilisation: Perinatal Risks and Early Childhood Outcomes

Document, J. R. (2012) · Human Fertility · doi:10.3109/14647273.2012.663571 · Cited by 26

Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome

Fernandez, E. D. T., Adams, K. V., Syed, M., Maranon, R. O., Romero, D. G., & Cardozo, L. L. Y. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00131 · Cited by 25

Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome

Tosi, F., Sarra, D. D., Bonin, C., Zambotti, F., Dall'Alda, M., Fiers, T., Kaufman, J., Donati, M., Franchi, M. P., Zanolin, M. E., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0761 · Cited by 26

Endocrinal and autoimmune linkage: Evidences from a controlled study of subjects with polycystic ovarian syndrome

Arora, S., Sinha, K., Kolte, S., & Mandal, A. (2016) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.178636 · Cited by 23

Evaluation of the Macula, Retinal Nerve Fiber Layer, and Choroid Thickness in Women With Polycystic Ovary Syndrome Using Spectral-Domain Optical Coherence Tomography

Açmaz, G., Ataş, M., Gülhan, A., Açmaz, B., Ataş, F., & Aksoy, H. (2014) · Reproductive Sciences · doi:10.1177/1933719114522523 · Cited by 25

Novel strategies in the management of polycystic ovary syndrome.

Spritzer, P. M., Motta, A. B., Sir‐Petermann, T., & Diamanti‐Kandarakis, E. (2015) · PubMed · Cited by 25

Metabolic screening in patients with polycystic ovary syndrome is largely underutilized among obstetrician-gynecologists

Dhesi, A. S., Murtough, K. L., Lim, J. K., Schulkin, J. A., McGovern, P. G., Power, M. L., & Morelli, S. S. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.07.043 · Cited by 25

Visceral adiposity index: Simple Tool for assessing cardiometabolic risk in women with polycystic ovary syndrome

Aggarwal, K., Agrawal, H., & Jain, A. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_559_18 · Cited by 25

The prevalence and phenotypic manifestations of polycystic ovary syndrome (PCOS) among infertile Sudanese women: a cross-sectional study

Elasam, A. N., Ahmed, M. A., Ahmed, A. B. A., Sharif, M. E., Abusham, A. A., Hassan, B., & Adam, I. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01762-6 · Cited by 25

A meta-analysis of effects of vitamin E supplementation alone and in combination with omega-3 or magnesium on polycystic ovary syndrome

Heidari, H., Hajhashemy, Z., & Saneei, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-24467-0 · Cited by 33

Hormonal contraception in women with the metabolic syndrome: A narrative review

Verhaeghe, J. (2010) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2010.502583 · Cited by 26

Prevalence of elevated glycated hemoglobin in women with polycystic ovary syndrome

Kim, J., Choi, Y. M., Cho, Y. M., Jung, H. S., Chae, S. J., Hwang, K. R., Hwang, S.-S., Ku, S., Kim, S. H., Kim, J. G., et al. (2012) · Human Reproduction · doi:10.1093/humrep/des039 · Cited by 25

A mass spectrometric insight into the origins of benign gynecological disorders

Yang, H., Lau, W. B., Lau, B., Yu, X., Zhou, S., Zhao, L., Luo, Z., Lin, Q., Ren, N., Zhao, X., et al. (2015) · Mass Spectrometry Reviews · doi:10.1002/mas.21484 · Cited by 25

Increased levels of serum granzyme-B is associated with insulin resistance and increased cardiovascular risk in adolescent polycystic ovary syndrome patients

Öztaş, E., Özler, S., Tokmak, A., Yılmaz, N., Çelik, H. T., Kazancı, F. H., Danışman, N., Ergin, M., & Yakut, H. İ. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.01.009 · Cited by 25

Proteomic Profiling for Identification of Novel Biomarkers Differentially Expressed in Human Ovaries from Polycystic Ovary Syndrome Patients

Li, L., Zhang, J., Deng, Q., Li, J., Li, Z., Xiao, Y., Hu, S., Li, T., Tan, Q., Li, X., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164538 · Cited by 25

Environmental toxin exposure in polycystic ovary syndrome women and possible ovarian neoplastic repercussion

Soave, I., Occhiali, T., Assorgi, C., Marci, R., & Caserta, D. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1729108 · Cited by 45

Neuroendocrine mechanisms responsible for elevated gonadotrophin‐releasing hormone and luteinising hormone pulses in polycystic ovary syndrome

Moore, A. M. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.70028 · Cited by 35

Metabolic and androgen profile in underweight women with polycystic ovary syndrome

Anastasiou, O. E., Canbay, A. E., Führer, D., & Tan, S. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4422-9 · Cited by 24

Abnormal irisin level in serum and endometrium is associated with metabolic dysfunction in polycystic ovary syndrome patients

Wang, W., Guo, Y. C., Zhang, X., & Zheng, J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13805 · Cited by 24

The efficacy of Tung’s acupuncture for sex hormones in polycystic ovary syndrome: A randomized controlled trial

Cao, Y., Chen, H., Zhao, D., Zhang, L., Yu, X., Zhou, X., & Liu, Z. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.04.016 · Cited by 24

Obesity, but not hyperandrogenism or insulin resistance, predicts skeletal muscle mass in reproductive‐aged women with polycystic ovary syndrome: A systematic review and meta‐analysis of 45 observational studies

Kazemi, M., Pierson, R. A., Parry, S. A., Kaviani, M., & Chilibeck, P. D. (2021) · Obesity Reviews · doi:10.1111/obr.13255 · Cited by 24

Cardiovascular Risk According to Body Mass Index in Women of Reproductive Age With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

Zhuang, C., Wang, Q., Wang, W., Sun, R., Zhang, F., & Yu, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.822079 · Cited by 29

Evaluation of Cardiovascular Disease Risk in Women having Poly Cystic Ovarian Syndrome

Rao, G. (2021) · Journal of Cardiology and Cardiovascular Research · doi:10.37191/mapsci-jccr-2(3)-036

Polycystic ovary syndrome: associations with cardiovascular disease

Benham, J. L., Goldberg, A., Teede, H. J., & Tay, C. T. (2023) · Climacteric · doi:10.1080/13697137.2023.2282689 · Cited by 20

Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)

Geraci, G., Riccio, C., Oliva, F. G., Gabrielli, D., Colivicchi, F., Grimaldi, M., Facchinetti, F., & Unfer, V. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1520490 · Cited by 19

Polycystic Ovarian Syndrome: An Evidence-based Approach to Evaluation and Management of Diabetes and Cardiovascular Risks for Today??s Clinician

Lorenz, L. B., & Wild, R. A. (2007) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31802f5197 · Cited by 43

Polycystic Ovary Syndrome and Cardiovascular Risk

Moore, M. E., Hirani, R., Khessib, S., Chirumamilla, A. P., Frishman, W. H., & Etienne, M. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001453